Fenfluramine Recruiting Phase 2 Trials for CDD Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03861871Fenfluramine in CDKL5 Deficiency Disorder (CDD)